JERCX
Price
$11.85
Change
-$0.06 (-0.50%)
Updated
Dec 4 closing price
Net Assets
295.07M
MGLMX
Price
$16.52
Change
-$0.11 (-0.66%)
Updated
Dec 4 closing price
Net Assets
2.18B
Interact to see
Advertisement

JERCX vs MGLMX

Header iconJERCX vs MGLMX Comparison
Open Charts JERCX vs MGLMXBanner chart's image
Janus Henderson Global Real Estate C
Price$11.85
Change-$0.06 (-0.50%)
VolumeN/A
Net Assets295.07M
MFS Global Real Estate R4
Price$16.52
Change-$0.11 (-0.66%)
VolumeN/A
Net Assets2.18B
JERCX vs MGLMX Comparison Chart in %
View a ticker or compare two or three
VS
JERCX vs. MGLMX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JERCX is a StrongBuy and MGLMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MGLMX has more cash in the bank: 2.18B vs. JERCX (295M). MGLMX pays higher dividends than JERCX: MGLMX (2.48) vs JERCX (2.33). JERCX was incepted earlier than MGLMX: JERCX (18 years) vs MGLMX (11 years). JERCX (1.84) is less costly to investors than MGLMX (0.95). JERCX is a more actively managed with annual turnover of: 87.00 vs. MGLMX (48.00). MGLMX has a lower initial minimum investment than JERCX: MGLMX (0) vs JERCX (2500). JERCX annual gain was more profitable for investors over the last year : 3.19 vs. MGLMX (-3.00). MGLMX return over 5 years is better than : 1.78 vs. JERCX (1.67).
JERCXMGLMXJERCX / MGLMX
Total Expense Ratio1.790.94190%
Annual Report Gross Expense Ratio1.840.95194%
Fund Existence18 years11 years-
Gain YTD9.2333.549260%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets295M2.18B14%
Annual Yield % from dividends2.332.4894%
Returns for 1 year3.19-3.00-106%
Returns for 3 years12.322.99412%
Returns for 5 years1.671.7894%
Returns for 10 years37.7624.74153%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CPOCX19.270.47
+2.50%
Morgan Stanley Insight L
DTCAX21.060.04
+0.19%
BNY Mellon Sust US Equity A
PCAQX92.620.09
+0.10%
Principal Capital Appreciation R5
IPHYF1.99N/A
N/A
Innate Pharma
PRPRF0.02N/A
N/A
Prairie Provident Resources Inc